Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Botta

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Cardiology Clinics|May 11, 2010
Biomarkers for diagnosis in thoracic aortic disease: PRODonald M Botta
Annali Dell'Istituto Superiore Di Sanita|January 1, 1997
Congenital malformations in infants of 517 pregestational diabetic mothersR M Botta
Current Medicinal Chemistry|December 17, 2008
Small molecules ATP-competitive inhibitors of FLT3: a chemical overviewS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|November 6, 2007
Antiangiogenic agents: an update on small molecule VEGFR inhibitorsS Schenone, F Bondavalli, M Botta
Mini Reviews in Medicinal Chemistry|February 20, 2007
Last findings on dual inhibitors of abl and SRC tyrosine-kinasesS Schenone, F Manetti, M Botta
Current Medicinal Chemistry|February 20, 2010
New opportunities to treat the T315I-Bcr-Abl mutant in chronic myeloid leukaemia: tyrosine kinase inhibitors and molecules that act by alternative mechanismsS Schenone, C Brullo, M Botta
Current Pharmaceutical Design|July 14, 2007
SRC inhibitors and angiogenesisS Schenone, F Manetti, M Botta
Acta Endocrinologica. Supplementum|January 1, 1986
Treatment of non insulin-dependent diabetic women during pregnancyG D Bompiani, R M Botta
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|April 6, 2012
Why are the intramyocardial portions of the coronary arteries spared from arteriosclerosis? Clinical implicationsDonald M Botta, John A Elefteriades
Clinical Journal of Oncology Nursing|November 20, 2018
Hemorrhagic Cystitis: Treatment With Hyperbaric Oxygen Therapy in Patients With Acute Lymphoblastic LeukemiaLauren M Botta, Gregory P Botta
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Cardiology Clinics|May 11, 2010
Biomarkers for diagnosis in thoracic aortic disease: PRODonald M Botta
Annali Dell'Istituto Superiore Di Sanita|January 1, 1997
Congenital malformations in infants of 517 pregestational diabetic mothersR M Botta
Current Medicinal Chemistry|December 17, 2008
Small molecules ATP-competitive inhibitors of FLT3: a chemical overviewS Schenone, C Brullo, M Botta
Current Medicinal Chemistry|November 6, 2007
Antiangiogenic agents: an update on small molecule VEGFR inhibitorsS Schenone, F Bondavalli, M Botta
Mini Reviews in Medicinal Chemistry|February 20, 2007
Last findings on dual inhibitors of abl and SRC tyrosine-kinasesS Schenone, F Manetti, M Botta
Current Medicinal Chemistry|February 20, 2010
New opportunities to treat the T315I-Bcr-Abl mutant in chronic myeloid leukaemia: tyrosine kinase inhibitors and molecules that act by alternative mechanismsS Schenone, C Brullo, M Botta
Current Pharmaceutical Design|July 14, 2007
SRC inhibitors and angiogenesisS Schenone, F Manetti, M Botta
Acta Endocrinologica. Supplementum|January 1, 1986
Treatment of non insulin-dependent diabetic women during pregnancyG D Bompiani, R M Botta
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|April 6, 2012
Why are the intramyocardial portions of the coronary arteries spared from arteriosclerosis? Clinical implicationsDonald M Botta, John A Elefteriades
Clinical Journal of Oncology Nursing|November 20, 2018
Hemorrhagic Cystitis: Treatment With Hyperbaric Oxygen Therapy in Patients With Acute Lymphoblastic LeukemiaLauren M Botta, Gregory P Botta
Pageof 16